Cargando…
Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia
The Mental Health Centers for Intervention Development and Applied Research (CIDAR) program prioritized research to provide an evidence base for biomarker development. At the Zucker Hillside Hospital (ZHH), our CIDAR grant supported research on a comprehensive investigation of treatment response and...
Autor principal: | Malhotra, Anil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601718/ https://www.ncbi.nlm.nih.gov/pubmed/26333841 http://dx.doi.org/10.1093/schbul/sbv117 |
Ejemplares similares
-
Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes
por: Waters, Flavie, et al.
Publicado: (2017) -
Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
por: Rubio, Jose M, et al.
Publicado: (2022) -
Universal Health Coverage for Schizophrenia: A Global Mental Health Priority
por: Patel, Vikram
Publicado: (2016) -
Addressing the Needs of People with Schizophrenia in South Africa During the COVID-19 Pandemic
por: Thela, Lindokuhle, et al.
Publicado: (2022) -
Heterogeneity of tissue-resident immunity across organs and in health and disease
por: Arck, Petra Clara, et al.
Publicado: (2022)